Typhoid vaccine study for children in Bangladesh
Part of Infections clinical trials.
This study tests a new typhoid vaccine (called ZyVac-TCV) in children and adolescents. It aims to protect them from typhoid fever, a serious bacterial infection, and will compare the vaccine to the usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 15 years old (up to 15 years and 364 days).
- Your child must live in the study area during the vaccination and plan to stay for the next 12 months.
- You (as parent or guardian) must be willing to give permission, and if your child is 11–15, they must also agree.
- Your child should be healthy with no fever on the day of the vaccination.
- Your child must not have had a typhoid vaccine before, and must not have known allergies to vaccines.
- Your child must not be pregnant (married girls will have a urine test), have immune problems, or have been in another trial in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
This study is checking how long the protection from a typhoid vaccine (called Bio TCV) lasts in people in Indonesia, compared to another vaccine. You would need to provide blood samples over time to see if your protection is still strong.
This study gives (or follows) typhoid and/or cholera vaccines and measures how your immune system responds. It is done in adults who are already scheduled for an upper endoscopy (EGD) and/or colonoscopy, using small tissue samples if appropriate.
This trial tests an experimental vaccine designed to protect against multiple types of Salmonella bacteria (which cause typhoid fever and other infections). It is given to healthy adults aged 18 to 45 to check safety and immune response.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
Hear when a new Typhoid Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.